Recent advances in therapies for eating disorders

F1000Res. 2019 Sep 26:8:F1000 Faculty Rev-1693. doi: 10.12688/f1000research.19847.1. eCollection 2019.

Abstract

Eating disorders are serious psychiatric illnesses with high rates of morbidity and mortality. Effective treatments have traditionally included behaviorally focused therapies as well as several medication strategies. Recent years have seen promising developments in these treatments, including additional support for family-based approaches for children and adolescents, new evidence for "third-wave" behavioral therapies, and new support for the use of lisdexamfetamine for binge eating disorder and olanzapine for anorexia nervosa. Case study and pilot data are beginning to show limited support for neuromodulatory interventions targeting brain regions thought to be involved in eating disorders. This review summarizes treatment developments over the last several years and points towards future directions for the field.

Keywords: Eating disorders.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Anorexia Nervosa* / therapy
  • Behavior Therapy
  • Binge-Eating Disorder* / therapy
  • Central Nervous System Stimulants / therapeutic use
  • Child
  • Feeding and Eating Disorders* / therapy
  • Humans
  • Lisdexamfetamine Dimesylate / therapeutic use

Substances

  • Central Nervous System Stimulants
  • Lisdexamfetamine Dimesylate

Grants and funding

The author(s) declared that no grants were involved in supporting this work.